✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Hikal Ltd.

HIKAL

Market Cap
₹5,142 Cr.
P/E
68.95

Hikal Ltd.

  • Hikal
  • Suven Life Sciences
  • Piramal Pharma
  • TJI Pharma - API & CRAMS
FAQs on Hikal Ltd. Shareprice

Hikal has given lower returns compared to its competitors.
Hikal has grown at ~19.07% over the last 2yrs while peers have grown at a median rate of 27.11%

Yes, Hikal is expensive.
Latest PE of Hikal is 68.95, while 3 year average PE is 43.63.
Also latest EV/EBITDA of Hikal is 19.66 while 3yr average is 16.91.

View FAQ's On Business
Growth Table
  • Hikal Ltd.
  • Suven Life Sciences
  • Piramal Pharma
Balance Sheet
  • Hikal Ltd.
  • Suven Life Sciences
  • Piramal Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Hikal Ltd.
  • Suven Life Sciences
  • Piramal Pharma
Cash Flow
  • Hikal Ltd.
  • Suven Life Sciences
  • Piramal Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Hikal Ltd.
  • Suven Life Sciences
  • Piramal Pharma
Quarterly Results
  • Hikal Ltd.
  • Suven Life Sciences
  • Piramal Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Hikal Ltd. Financials

Balance sheet of Hikal is strong.
But short term working capital might become an issue for this company.

The debt of Hikal is decreasing.
Latest debt of Hikal is ₹744 Crs as of Sep-24.
This is less than Mar-24 when it was ₹773 Crs.

The profit is oscillating.
The profit of Hikal is ₹74.57 Crs for TTM, ₹69.6 Crs for Mar 2024 and ₹78.38 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Hikal latest dividend payout ratio is 21.26% and 3yr average dividend payout ratio is 17.48%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech